Cell Reports (Oct 2016)

Non-oncogenic Acute Viral Infections Disrupt Anti-cancer Responses and Lead to Accelerated Cancer-Specific Host Death

  • Frederick J. Kohlhapp,
  • Erica J. Huelsmann,
  • Andrew T. Lacek,
  • Jason M. Schenkel,
  • Jevgenijs Lusciks,
  • Joseph R. Broucek,
  • Josef W. Goldufsky,
  • Tasha Hughes,
  • Janet P. Zayas,
  • Hubert Dolubizno,
  • Ryan T. Sowell,
  • Regina Kühner,
  • Sarah Burd,
  • John C. Kubasiak,
  • Arman Nabatiyan,
  • Sh’Rae Marshall,
  • Praveen K. Bommareddy,
  • Shengguo Li,
  • Jenna H. Newman,
  • Claude E. Monken,
  • Sasha H. Shafikhani,
  • Amanda L. Marzo,
  • Jose A. Guevara-Patino,
  • Ahmed Lasfar,
  • Paul G. Thomas,
  • Edmund C. Lattime,
  • Howard L. Kaufman,
  • Andrew Zloza

DOI
https://doi.org/10.1016/j.celrep.2016.09.068
Journal volume & issue
Vol. 17, no. 4
pp. 957 – 965

Abstract

Read online

In light of increased cancer prevalence and cancer-specific deaths in patients with infections, we investigated whether infections alter anti-tumor immune responses. We report that acute influenza infection of the lung promotes distal melanoma growth in the dermis and leads to accelerated cancer-specific host death. Furthermore, we show that during influenza infection, anti-melanoma CD8+ T cells are shunted from the tumor to the infection site, where they express high levels of the inhibitory receptor programmed cell death protein 1 (PD-1). Immunotherapy to block PD-1 reverses this loss of anti-tumor CD8+ T cells from the tumor and decreases infection-induced tumor growth. Our findings show that acute non-oncogenic infection can promote cancer growth, raising concerns regarding acute viral illness sequelae. They also suggest an unexpected role for PD-1 blockade in cancer immunotherapy and provide insight into the immune response when faced with concomitant challenges.

Keywords